9:22 AM
Leo Group India
| ||
| Progenics Pharmaceuticals Announces First Quarter 2012 Financial Results MarketWatch (press release) TARRYTOWN, NY, May 8, 2012 (GlobeNewswire via COMTEX) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) today announced its results of operations for the quarter ended March 31. Net loss for the quarter was $13.1 million, or $0.39 basic and diluted per ... See all stories on this topic » | ||
| Par Pharmaceutical Companies Reports First Quarter 2012 Results MarketWatch (press release) WOODCLIFF LAKE, NJ, May 8, 2012 /PRNewswire via COMTEX/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the first quarter ended March 31, 2012. For the first quarter ended March 31, 2012, the Company reported total revenues ... See all stories on this topic » | ||
| Spectrum Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 ... MarketWatch (press release) HENDERSON, Nev., May 08, 2012 (BUSINESS WIRE) -- Spectrum Pharmaceuticals (nasdaqgs:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an ... See all stories on this topic » | ||
| FDA revisits safety of Arena Pharma's diet pill The Associated Press By MATTHEW PERRONE, AP Health Writer – 1 minute ago WASHINGTON (AP) — Federal health regulators are asking tough questions about the risk of tumors and heart problems with an experimental diet pill from Arena Pharmaceuticals, which was previously ... See all stories on this topic » | ||
| Savient Pharmaceuticals Enters Into Definitive Financing and Debt ... MarketWatch (press release) EAST BRUNSWICK, NJ, May 8, 2012 /PRNewswire via COMTEX/ -- Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the Company has entered into definitive agreements with certain holders of its currently outstanding 4.75% convertible senior ... See all stories on this topic » | ||
| AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results Sacramento Bee By AcelRx Pharmaceuticals, Inc. REDWOOD CITY, Calif., May 8, 2012 -- /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies ... See all stories on this topic » | ||
| Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of ... MarketWatch (press release) JERUSALEM, May 08, 2012 (BUSINESS WIRE) -- Oramed Pharmaceuticals Inc. (OBB:ORMP) ( http://www.oramed.com ), a developer of oral delivery systems, announced today that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant ... See all stories on this topic » | ||
| Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer ... MarketWatch (press release) ROCKVILLE, Md., May 08, 2012 (BUSINESS WIRE) -- Rexahn Pharmaceuticals, Inc. (ASE:RNN) , a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted ... See all stories on this topic » | ||
| Arena Pharma faces familiar safety questions in second bid for US approval of ... Washington Post WASHINGTON — Federal health regulators are asking tough questions about the risk of tumors and heart problems with an experimental diet pill from Arena Pharmaceuticals, which was previously rejected for similar safety concerns. See all stories on this topic » | ||
| Transcept Pharmaceuticals to Report First Quarter 2012 Financial Results and ... Sacramento Bee By Transcept Pharmaceuticals, Inc. POINT RICHMOND, Calif., May 7, 2012 -- /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment